Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 07:47 ET | Source: Curanex Pharmaceuticals Inc

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

Expanded case series includes advanced thymic carcinoma, small cell lung cancer, pancreatic cancer, end-stage liver cirrhosis, and end-stage renal disease According to patient accounts, multiple...
April 06, 2026 09:17 ET | Source: Curanex Pharmaceuticals Inc

Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care

Case involving senior dosimetrist at a premier cancer hospital in the Northeast suggests potential relevance of Phyto-N in one of oncology’s most serious and underserved supportive-care markets ...
April 02, 2026 08:07 ET | Source: Curanex Pharmaceuticals Inc

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals, Inc. (Nasdaq: CURX)...
March 30, 2026 05:13 ET | Source: Research and Markets

Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides critical insights, including market size...
January 19, 2026 06:41 ET | Source: Research and Markets

Cancer Cachexia Market Poised to Reach USD 3.90 Billion by 2033

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market Size, Share & Trends Analysis Report by Treatment (Appetite Stimulants, Corticosteroids), Type (Lung Cancer, Colorectal...
October 31, 2025 07:57 ET | Source: Research and Markets

Cancer Cachexia Market Trends and Growth Outlook (2025-2035) by Therapy Type, Stage of Cachexia, Distribution Channel and Region

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - A Global and Regional Analysis: Focus on Therapy Type, Stage of Cachexia, Distribution Channel, and Region - Analysis and...
August 07, 2025 13:00 ET | Source: DelveInsight Business Research LLP

Cancer Cachexia Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight

New York, USA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cancer Cachexia Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight The cancer cachexia...
August 23, 2024 11:51 ET | Source: Research and Markets

Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - Long-term Forecast to 2033

Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Cancer Cachexia Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global cancer cachexia market is forecast to...
April 05, 2024 09:27 ET | Source: Research and Markets

Cancer Cachexia Global Strategic Research Report 2024: Market to Reach $3.5 Billion by 2030, Driven by Promising Treatment Options

Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cancer Cachexia Market to Reach...
December 15, 2023 07:30 ET | Source: Transparency Market Research

Cancer Cachexia Market to Hit USD 3.6 billion by 2031, at a CAGR 4.7% | Says Transparency Market Research, Inc.

Wilmington, Delaware, United States, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cancer cachexia market was projected to attain US$ 2.2 billion in 2022. It is...